Circulating cell free tumor DNA detection as novel biomarkers to monitor desmoid tumors evolution.

11063Background: Since desmoid tumors (DT) exhibit an unpredictable clinical course, with stabilization and/or spontaneous regression, an initial “wait-and-see” policy is the new standard of care t...